Learn about hepatitis C, how it spreads, possible symptoms, and important steps to protect yourself and others from this ...

Premium InsightsThe Hepatitis C drug market is entering a transformative phase as global health organizations, pharmaceutical ...

Hospital admissions for hepatitis C among patients with HIV infection declined after policies were implemented to expand access to direct-acting antiviral therapy. Although expanded access to ...

Younger age, substance use, and HCC may be risk factors for repeat HCV viremia in patients who achieve SVR following DAA therapy.

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Atea’s Phase 3 trial evaluating the regimen of bemnifosbuvir and ruzasvir for the treatment of adults with chronic hepatitis C virus (HCV). C-BEYOND is an open-label trial being conducted in the ...

has announced the launch of a whole genome sequencing service to tackle hepatitis C virus (HCV). The service is aimed at monitoring drug resistance, detecting outbreaks sooner and improving efforts ...

AMALAPURAM: Health authorities in Konaseema district have reported a spike in hepatitis infections in Pallam village, following over 10 days of persistent fever ...

Despite universal hepatitis C virus (HCV) screening recommendations issued in 2020, HCV screening rates remain suboptimal among US women, a new analysis showed. “We found that screening rates ...

From a public health point of view, there are no specific strategies for prevention of hepatitis E virus infection. Exposures ...

Hepatitis C virus (HCV) and nonalcoholic fatty liver disease (NAFLD) are the two most common causes of chronic liver disease in North America. NAFLD represents a spectrum of liver lesions that ...